Search - tctmd.com

Displaying 261 - 280 of 349

Sort: Relevancy | Date

Presentation TCT 2016

Cardiogenic Shock and High-risk PCI: Patient Approach and Hemodynamic Support Devices

Presenter: Manish A. Parikh, Sahil A. Parikh

October 30, 2016

News Conference News TCT 2016

YELLOW II: Improved Cholesterol Efflux Linked to Plaque Stabilization in Statin-Treated Patients

Michael O'Riordan

October 29, 2016

News Conference News TCT 2016

Impella CP Fails to Show Benefit in Exploratory Study of Patients With Severe Cardiogenic Shock

Todd Neale

October 29, 2016

News Opinion Editor's Corner TCT 2016

TCT 2016: Inspiration and Perspiration Greet Left Main Stenting, Hoop Dreams, Valve Innovation, and Election Fever

Shelley Wood

October 24, 2016

Presentation TCT 2015

Case Resolution: How We Treated a Clinically High-Risk and Anatomically Complex Left Main Patient (With Long-term Follow-up)

Presenter: Davide Capodanno, Gregg W. Stone, Nicholas J. Lembo

October 15, 2015

Presentation TCT 2015

Case Introduction: PCI or CABG? A Clinically High-Risk and Anatomically Complex Left Main Patient

Presenter: Davide Capodanno, Gregg W. Stone, Nicholas J. Lembo

October 15, 2015

Presentation TCT 2015

Just How Effective Is Hypothermia in Cardiac Arrest?

Presenter: Tanveer Rab, Holger Thiele, Michel R. Le May

October 14, 2015

Presentation TCT 2015

The Role (and Timing) of Complete Revascularization in AMI and Cardiogenic Shock

Presenter: Tanveer Rab, Holger Thiele

October 14, 2015

Presentation TCT 2015

Escalation Therapies and RV Dysfunction: New Opportunities

Presenter: Tanveer Rab, Holger Thiele, Navin K. Kapur

October 14, 2015

Presentation TCT 2015

Debate: What Support Device Should Most Frequently Be Used in Cardiogenic Shock? ECMO for True Shock!

Presenter: Tanveer Rab, Holger Thiele, Aly El Banayosy

October 14, 2015

Presentation TCT 2015

Debate: What Support Device Should Most Frequently Be Used in Cardiogenic Shock? IABP Is Still Frontline!

Presenter: Tanveer Rab, Holger Thiele, Sunil V. Rao

October 14, 2015

Presentation TCT 2015

What Support Device Should Most Frequently Be Used in Cardiogenic Shock? Impella for Most!

Presenter: Tanveer Rab, Holger Thiele, Jose P.S. Henriques

October 14, 2015

Presentation TCT 2015

The Spectrum of Hemodynamic Support Options for Shock

Presenter: Tanveer Rab, Holger Thiele, Vladimir Dzavik

October 14, 2015

Presentation TCT 2015

The Role of the Life Vest, ICDs, and BiV Pacing in Patients With LV Dysfunction

Presenter: Robert O. Bonow, Ajay J. Kirtane, William T. Abraham

October 14, 2015

Presentation TCT 2015

Temporary Cardiac Support During High-Risk PCI: HeartMate PHP and the SHIELD I Study

Presenter: Robert O. Bonow, Ajay J. Kirtane, David E. Kandzari

October 14, 2015

Presentation TCT 2015

The Role of Hemodynamic Support in Nonemergent PCI and LV Dysfunction

Presenter: Robert O. Bonow, Ajay J. Kirtane, Brij Maini

October 14, 2015

Presentation TCT 2015

Case Presentation: How We Treated MVD With LV Dysfunction With Intermediate SYNTAX Score

Presenter: Robert O. Bonow, Ajay J. Kirtane, Adriano Caixeta

October 14, 2015

Presentation TCT 2015

I Would Treat This Patient With PCI

Presenter: Robert O. Bonow, Ajay J. Kirtane

October 14, 2015

Presentation TCT 2015

I Would Treat This Patient With Surgery

Presenter: Robert O. Bonow, Ajay J. Kirtane, Joseph F. Sabik

October 14, 2015

Presentation TCT 2015

I Would Treat This Patient Conservatively (Medications First)

Presenter: Robert O. Bonow, Ajay J. Kirtane, Mark Goldberger

October 14, 2015

Advertisement

Cardiogenic Shock and High-risk PCI: Patient Approach and Hemodynamic Support Devices

YELLOW II: Improved Cholesterol Efflux Linked to Plaque Stabilization in Statin-Treated Patients

Impella CP Fails to Show Benefit in Exploratory Study of Patients With Severe Cardiogenic Shock

TCT 2016: Inspiration and Perspiration Greet Left Main Stenting, Hoop Dreams, Valve Innovation, and Election Fever

Case Resolution: How We Treated a Clinically High-Risk and Anatomically Complex Left Main Patient (With Long-term Follow-up)

Case Introduction: PCI or CABG? A Clinically High-Risk and Anatomically Complex Left Main Patient

Just How Effective Is Hypothermia in Cardiac Arrest?

The Role (and Timing) of Complete Revascularization in AMI and Cardiogenic Shock

Escalation Therapies and RV Dysfunction: New Opportunities

Debate: What Support Device Should Most Frequently Be Used in Cardiogenic Shock? ECMO for True Shock!

Debate: What Support Device Should Most Frequently Be Used in Cardiogenic Shock? IABP Is Still Frontline!

What Support Device Should Most Frequently Be Used in Cardiogenic Shock? Impella for Most!

The Spectrum of Hemodynamic Support Options for Shock

The Role of the Life Vest, ICDs, and BiV Pacing in Patients With LV Dysfunction

Temporary Cardiac Support During High-Risk PCI: HeartMate PHP and the SHIELD I Study

The Role of Hemodynamic Support in Nonemergent PCI and LV Dysfunction

Case Presentation: How We Treated MVD With LV Dysfunction With Intermediate SYNTAX Score

I Would Treat This Patient With PCI

I Would Treat This Patient With Surgery

I Would Treat This Patient Conservatively (Medications First)

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content